Resistance to Ibritumomab in Lymphoma
This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumom...
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Hosono, Makoto (Editor, http://id.loc.gov/vocabulary/relators/edt), Chatal, Jean-François (Editor, http://id.loc.gov/vocabulary/relators/edt) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
| Edition: | 1st ed. 2018. |
| Series: | Resistance to Targeted Anti-Cancer Therapeutics,
18 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Similar Items
-
Resistance to Targeted Therapies in Lymphomas
Published: (2019) -
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
Published: (2018) -
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways
Published: (2018) -
Breast Cancer Metastasis and Drug Resistance Challenges and Progress /
Published: (2019) -
Current Applications for Overcoming Resistance to Targeted Therapies
Published: (2019)